Bayer reported €4.18 billion in third-quarter losses, mainly due to agricultural division asset impairment. Revenues fell 3.6% to €9.97 billion, with agriculture down 8.7% and pharmaceuticals...
The figures in the pharmaceuticals area are cemented especially by the performance of Bayer's cardiovascular treatments and for the prevention of age-related ophthalmological diseases. Another highlight...